These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3606468)

  • 1. Metabolism of human intermediate and very low density lipoprotein subfractions from normal and dysbetalipoproteinemic plasma. In vivo studies in rat.
    Musliner TA; McVicker KM; Iosefa JF; Krauss RM
    Arteriosclerosis; 1987; 7(4):408-20. PubMed ID: 3606468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of multiple subpopulations of lipoproteins of intermediate density in normal subjects.
    Musliner TA; Giotas C; Krauss RM
    Arteriosclerosis; 1986; 6(1):79-87. PubMed ID: 3942562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fish oil supplementation reduces beta-very low density lipoprotein in type III dysbetalipoproteinemia.
    Dallongeville J; Boulet L; Davignon J; Lussier-Cacan S
    Arterioscler Thromb; 1991; 11(4):864-71. PubMed ID: 2065040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IDL, VLDL, chylomicrons and atherosclerosis.
    Nordestgaard BG; Tybjaerg-Hansen A
    Eur J Epidemiol; 1992 May; 8 Suppl 1():92-8. PubMed ID: 1505659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
    Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
    Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural heterogeneity of apoB-containing serum lipoproteins visualized using cryo-electron microscopy.
    van Antwerpen R; La Belle M; Navratilova E; Krauss RM
    J Lipid Res; 1999 Oct; 40(10):1827-36. PubMed ID: 10508202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of high cholesterol diets on rat plasma lipoproteins and lipoprotein-cell interactions.
    Cole TG; Kuisk I; Patsch W; Schonfeld G
    J Lipid Res; 1984 Jun; 25(6):593-603. PubMed ID: 6431045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance of a very low density lipoprotein subpopulation from familial dysbetalipoproteinemia to in vitro lipolytic conversion to the low density lipoprotein density fraction.
    Chung BH; Segrest JP
    J Lipid Res; 1983 Sep; 24(9):1148-59. PubMed ID: 6631244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperbetalipoproteinemia with small low-density lipoprotein, a characteristic disorder of lipoprotein in essential hypertension.
    Ikeda K; Suzuki M; Ikebuchi M; Hara Y; Tsushima M; Yamamoto A; Harano Y
    J Diabetes Complications; 1995; 9(4):227-9. PubMed ID: 8573733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of plasma VLDL and IDL precursors into various LDL subpopulations using density gradient ultracentrifugation.
    Marzetta CA; Foster DM; Brunzell JD
    J Lipid Res; 1990 Jun; 31(6):975-84. PubMed ID: 2373965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).
    Chappell DA
    J Clin Invest; 1989 Dec; 84(6):1906-15. PubMed ID: 2556448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bezafibrate on apolipoprotein B metabolism in type III hyperlipoproteinemic subjects.
    Packard CJ; Clegg RJ; Dominiczak MH; Lorimer AR; Shepherd J
    J Lipid Res; 1986 Sep; 27(9):930-8. PubMed ID: 3783047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is hypertriglyceridemic very low density lipoprotein a precursor of normal low density lipoprotein?
    Oschry Y; Olivecrona T; Deckelbaum RJ; Eisenberg S
    J Lipid Res; 1985 Feb; 26(2):158-67. PubMed ID: 3989374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma apolipoprotein B metabolism in familial type III dysbetalipoproteinaemia.
    Turner PR; Cortese C; Wootton R; Marenah C; Miller NE; Lewis B
    Eur J Clin Invest; 1985 Apr; 15(2):100-12. PubMed ID: 3922766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperapobetalipoproteinemia with compositional abnormality of LDL and IDL, a characteristic lipoprotein alteration in essential hypertension.
    Ryomoto KI; Suzuki M; Kanazawa A; Hasegawa M; Kimura Y; Yamamura T; Harano Y
    Am J Hypertens; 2000 Jun; 13(6 Pt 1):617-24. PubMed ID: 10912744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma lipoprotein changes during abstinence in chronic alcoholics.
    Weidman SW; Beard JD; Sabesin SM
    Atherosclerosis; 1984 Aug; 52(2):151-66. PubMed ID: 6433939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of apolipoproteins C-II, C-III, and B in hypertriglyceridemic men. Changes after heparin-induced lipolysis.
    Huff MW; Breckenridge WC; Strong WL; Wolfe BM
    Arteriosclerosis; 1988; 8(5):471-9. PubMed ID: 3190554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma lipoproteins in the golden Syrian hamster (Mesocricetus auratus): heterogeneity of apoB- and apoA-I-containing particles.
    Goulinet S; Chapman MJ
    J Lipid Res; 1993 Jun; 34(6):943-59. PubMed ID: 8354960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of intermediate and low-density lipoprotein subspecies to risk of coronary artery disease.
    Krauss RM
    Am Heart J; 1987 Feb; 113(2 Pt 2):578-82. PubMed ID: 3544774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.